Valuation: RushNet, Inc.

Market Cap 12.26M 10.63M 10.03M 9.1M 17.07M 1.18B 17.19M 120M 46.15M 596M 46.06M 45.05M 1.9B P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 18.19M 15.76M 14.88M 13.5M 25.32M 1.74B 25.5M 178M 68.47M 885M 68.33M 66.83M 2.81B EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.02
Manager TitleAgeSince
Chief Executive Officer - 2024-03-03
Chief Operating Officer 45 2021-08-01
Director TitleAgeSince
Chairman - 2024-03-03
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 8.77K
+4.82%-1.70%-9.41%+52.90% 7.05B
+2.02%-0.17%-7.52%-18.05% 4B
+3.10%+5.85%+29.09% - 2.7B
+1.63%+0.13%-12.38%-30.97% 1.54B
+0.86%-14.55%+61.51%+1,863.79% 1.35B
+2.64%-2.35%-19.39%-16.48% 1.3B
-1.82%-5.38%+93.24% - 1.02B
-0.52%+0.68%-29.16%-19.76% 808M
+1.40%+12.41%+3.76%+10.51% 799M
Average +1.44%-2.22%+12.19%+263.13% 2.06B
Weighted average by Cap. +2.77%-3.27%+4.62%+162.33%

Financials

2020 2021
Net sales 4.39M 3.8M 3.59M 3.26M 6.11M 421M 6.15M 42.85M 16.51M 213M 16.48M 16.12M 678M 5.9M 5.11M 4.82M 4.37M 8.21M 565M 8.27M 57.59M 22.19M 287M 22.15M 21.66M 912M
Net income 991K 858K 810K 735K 1.38M 94.96M 1.39M 9.68M 3.73M 48.17M 3.72M 3.64M 153M 164K 142K 134K 121K 228K 15.68M 229K 1.6M 616K 7.95M 614K 601K 25.28M
Net Debt 5.87M 5.09M 4.8M 4.35M 8.17M 563M 8.23M 57.33M 22.09M 285M 22.05M 21.56M 907M 5.93M 5.14M 4.85M 4.4M 8.25M 568M 8.31M 57.9M 22.31M 288M 22.27M 21.78M 916M
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
26-09-14 $0.000001 0.00% 380,200
26-09-11 $0.000001 0.00% 140,000
  1. Stock Market
  2. Stocks
  3. RSHN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!